# Dexamethasone in Preventing Hearing Loss in Patients Receiving Cisplatin

> **NCT02382068** · NA · WITHDRAWN · sponsor: **Aaron Moberly**

## Conditions studied

- Malignant Neoplasm
- Ototoxicity

## Interventions

- **DRUG:** Dexamethasone
- **OTHER:** Placebo
- **DRUG:** Cisplatin

## Key facts

- **NCT ID:** NCT02382068
- **Lead sponsor:** Aaron Moberly
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-08
- **Primary completion:** 2017-07
- **Final completion:** 2017-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No patients were enrolled to trial
- **Last updated:** 2017-11-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02382068

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02382068, "Dexamethasone in Preventing Hearing Loss in Patients Receiving Cisplatin". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT02382068. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*